Healthcare -
Biotechnology - NASDAQ - US
$ 4.8325
124 %
$ 15 M
Market Cap
-0.15
P/E
BTAI - OPERATING EXPENSES
Operating Expenses BTAI - BioXcel Therapeutics, Inc.
172 M
LAST VALUE
26.79%
2 YEAR CAGR
53.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR